Galt Appoints Former Merck & Co. Senior Vice President Dr. Louis Sherwood to Board of Directors; Sherwood to Help Drive Drug Safety Company's Direction and Growth.Business/Technology Editors & Health/Medical Writers STERLING, Va.--(BW HealthWire)--June 17, 2002 Galt Associates, Inc., provider of drug safety and marketing software and services, announced today that Dr. Louis M. Sherwood has accepted an appointment to its Board of Directors. Dr. Sherwood retired on April 1, 2002 as Senior Vice President for Medical and Scientific Affairs in the U.S. Human Health Division of Merck & Co. and currently serves as Adjunct Professor of Medicine at the University of Pennsylvania (body, education) University of Pennsylvania - The home of ENIAC and Machiavelli. http://upenn.edu/. Address: Philadelphia, PA, USA. and Visiting Professor of Medicine at the Albert Einstein College of Medicine
The Albert Einstein College of Medicine (AECOM) is a graduate school of Yeshiva University. It is a private medical school located in the Jack and Pearl Resnick Campus of Yeshiva University in the Morris Park . "As past President of the American Society for Clinical Investigation and as recent recipient of the first Lifetime Achievement in Pharmaceutical Medicine Award from the American Academy of Pharmaceutical Physicians, Dr. Sherwood brings extensive knowledge on the strategic application of outcomes and safety information to Galt," said Tim Howard, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Galt. "His participation on numerous academic and scientific boards combined with his insights into the challenges facing pharmaceutical executives will also give us a unique and invaluable perspective." "Galt provides the pharmaceutical and biotechnology marketplace with critical drug safety solutions and services," remarked Sherwood. "I look forward to working with the Galt team to enhance further the company's market leadership in the delivery of benefit-risk programs to the industry." Dr. Sherwood brings to Galt extensive expertise from more than four decades in both academic medicine and the pharmaceutical industry. During the last decade, as Merck's Chief Medical Officer in the United States, Dr. Sherwood was responsible for all medical activities in the U.S. market. At Merck, he previously served as Executive Vice-President for Worldwide Development in the Merck Research Laboratories and Senior Vice-President in the International Division. Prior to joining Merck, he served for seven years as Baumritter Professor and Chairman of the Department of Medicine, Albert Einstein College of Medicine and as Physician-in-Chief at Montefiore Medical Center Montefiore Medical Center, in the Bronx, New York, is the university hospital of the Albert Einstein College of Medicine. The hospital, named after Moses Montefiore, is one of the 50 largest employers in New York State [1]. , New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of . Dr. Sherwood had previously been Professor of Medicine at the University of Chicago and Chairman of Medicine at Michael Reese Medical Center, as well as Associate Professor at Harvard Medical School Harvard Medical School (HMS) is one of the graduate schools of Harvard University. It is a prestigious American medical school located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts. and Chief of Endocrinology at Boston's Beth Israel Hospital See:
About Galt's Solutions and Services Galt partners with biopharmaceutical clients in the development and execution of benefit-risk programs to help them accelerate adoption of new blockbuster products. The lifecycle benefit-risk programs are a formalization for·mal·ize tr.v. for·mal·ized, for·mal·iz·ing, for·mal·iz·es 1. To give a definite form or shape to. 2. a. To make formal. b. of the research services Galt has offered its clients over the past seven years. Galt's software products and surveillance services enable clients around the world to easily adapt to current and upcoming global regulations for electronically submitting adverse drug reactions adverse drug reaction, n a detrimental outcome from a drug. Two types of ADRs exist: Type 1 results from dosage mismatch and Type 2 from rare conditions often as a consequence of a small dose. See also risk or sensitive type. . About Galt Galt is a world-wide provider of safety and marketing information to the pharmaceutical and medical device industries. Galt's premier products, dsNavigator(TM), dsGateway(TM) and dsMonitor(TM), in combination with the company's Benefit-risk Programs, Research Services, and Surveillance Services significantly enhance a pharmaceutical manufacturer's ability to strategically position products and identify opportunities for product differentiation Product Differentiation A source of competitive advantage that depends on producing some item that is regarded to have unique and valuable characteristics. . Galt's current Web-site offerings, DrugSafety.com and Informatics-Online.com, support the worldwide pharmacovigilance, outcomes, marketing, research and medical informatics medical informatics, n the field of information science concerned with the analysis and dissemination of medical data through the application of computers to various aspects of health care and medicine. sectors through convenient online resources and data access application suites. For more information about Galt, visit DrugSafety.com, or call Liz Allan, Director of Marketing Communications at 703-433-6104. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion